{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:10:11Z","timestamp":1791598211968,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T00:00:00Z","timestamp":1507939200000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008731","name":"Nakatomi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004095","name":"Kyowa Hakko Kirin","doi-asserted-by":"publisher","award":["MOP-97946"],"award-info":[{"award-number":["MOP-97946"]}],"id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ajgponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jagp.2016.04.013","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T17:53:04Z","timestamp":1462384384000},"page":"1028-1039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Benzodiazepine Use Attenuates Cortical \u03b2-Amyloid and is Not Associated with Progressive Cognitive Decline in Nondemented Elderly Adults: A Pilot Study Using F18-Florbetapir Positron Emission Tomography"],"prefix":"10.1016","volume":"24","author":[{"given":"Jun Ku","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichiro","family":"Shinagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Plitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Mallar","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Caravaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce G.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gerretsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Graff-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2016.04.013_bib0010","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.JGP.0000218218.47279.db","article-title":"Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: prevalence and relationship with dementia severity","volume":"14","author":"Tatsch","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2016.04.013_bib0015","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1523\/JNEUROSCI.5663-11.2012","article-title":"Benzodiazepines modulate GABAA receptors by regulating the preactivation step after GABA binding","volume":"32","author":"Gielen","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.jagp.2016.04.013_bib0020","first-page":"146","article-title":"Benzodiazepine-induced amnesia and anaesthetic practice: a review","volume":"6","author":"O'Boyle","year":"1988","journal-title":"Psychopharmacol Ser"},{"key":"10.1016\/j.jagp.2016.04.013_bib0025","first-page":"639","article-title":"A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs","volume":"29","author":"Tannenbaum","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jagp.2016.04.013_bib0030","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004714-200206000-00009","article-title":"Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology ofVascular Aging Study","volume":"22","author":"Paterniti","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jagp.2016.04.013_bib0035","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer's disease: case-control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jagp.2016.04.013_bib0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ageing\/afn277","article-title":"The risk of cognitive impairment in older community-dwelling women after benzodiazepine use","volume":"38","author":"Lagnaoui","year":"2009","journal-title":"Age Ageing"},{"key":"10.1016\/j.jagp.2016.04.013_bib0045","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2165\/00002512-200724120-00007","article-title":"Associations between use of benzodiazepines or related drugs and health, physical abilities and cognitive function: a non-randomised clinical study in the elderly","volume":"24","author":"Puustinen","year":"2007","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jagp.2016.04.013_bib0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/WAD.0000000000000099","article-title":"Benzodiazepine use and cognitive decline in elderly with normal cognition","volume":"30","author":"Zhang","year":"2016","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jagp.2016.04.013_bib0055","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s40264-015-0319-3","article-title":"Benzodiazepine use and risk of developing alzheimer's disease or vascular dementia: a case-control analysis","volume":"38","author":"Imfeld","year":"2015","journal-title":"Drug Saf"},{"key":"10.1016\/j.jagp.2016.04.013_bib0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1176\/jnp.2010.22.2.130","article-title":"Psychopharmacological neuroprotection in neurodegenerative disease: heuristic clinical applications","volume":"22","author":"Lauterbach","year":"2010","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jagp.2016.04.013_bib0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00002093-199803000-00002","article-title":"Benzodiazepines may have protective effects against Alzheimer disease","volume":"12","author":"Fastbom","year":"1998","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jagp.2016.04.013_bib0070","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM199403033300907","article-title":"Excitatory amino acids as a final common pathway for neurologic disorders","volume":"330","author":"Lipton","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jagp.2016.04.013_bib0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0304-3940(94)90761-7","article-title":"6-Chloro-D,L-tryptophan, 4-chloro\u20133-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation","volume":"178","author":"Saito","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jagp.2016.04.013_bib0080","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.neuropharm.2005.06.015","article-title":"Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons","volume":"49","author":"Paula-Lima","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jagp.2016.04.013_bib0085","doi-asserted-by":"crossref","first-page":"14299","DOI":"10.1523\/JNEUROSCI.3383-10.2010","article-title":"Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice","volume":"30","author":"Tampellini","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.jagp.2016.04.013_bib0090","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s12640-014-9478-8","article-title":"Effects of repetitive exposure to anesthetics and analgesics in the Tg2576 mouse Alzheimer's model","volume":"26","author":"Quiroga","year":"2014","journal-title":"Neurotox Res"},{"key":"10.1016\/j.jagp.2016.04.013_bib0095","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbrc.2015.01.022","article-title":"Midazolam inhibits the formation of amyloid fibrils and GM1 ganglioside-rich microdomains in presynaptic membranes through the gamma-aminobutyricacid A receptor","volume":"457","author":"Yamamoto","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jagp.2016.04.013_bib0100","author":"Alzheimer's Disease Neuroimaging I"},{"key":"10.1016\/j.jagp.2016.04.013_bib0105","first-page":"598","article-title":"ADAS-cog (Alzheimer's Disease Assessment Scale-cognitive subscale)\u2014validation of the Slovak version","volume":"101","author":"Kolibas","year":"2000","journal-title":"Bratisl Lek Listy"},{"issue":"suppl 1","key":"10.1016\/j.jagp.2016.04.013_bib0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S1041610297004870","article-title":"Clinical Dementia Rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type","volume":"9","author":"Morris","year":"1997","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jagp.2016.04.013_bib0115","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jagp.2016.04.013_bib0120","series-title":"L \u2018examen Clinique en Psychologie [Clinical Tests in Psychology]","author":"Rey","year":"1964"},{"key":"10.1016\/j.jagp.2016.04.013_bib0125","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/gps.1010","article-title":"Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging","volume":"18","author":"Estevez-Gonzalez","year":"2003","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2016.04.013_bib0130","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2016.04.013_bib0135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","article-title":"Measurement of functional activities in older adults in the community","volume":"37","author":"Pfeffer","year":"1982","journal-title":"J Gerontol"},{"key":"10.1016\/j.jagp.2016.04.013_bib0140","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3233\/JAD-142931","article-title":"Lifetime history of depression predicts increased amyloid-beta accumulation in patients with mild cognitive impairment","volume":"45","author":"Chung","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2016.04.013_bib0145","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1074\/jbc.R109.080895","article-title":"Calcium signaling and amyloid toxicity in Alzheimer disease","volume":"285","author":"Demuro","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jagp.2016.04.013_bib0150","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1523\/JNEUROSCI.12-02-00376.1992","article-title":"Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity","volume":"12","author":"Mattson","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.jagp.2016.04.013_bib0155","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.euroneuro.2014.07.015","article-title":"Glutamate-mediated excitotoxicity in schizophrenia: a review","volume":"24","author":"Plitman","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jagp.2016.04.013_bib0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0006-8993(97)00043-7","article-title":"The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes","volume":"754","author":"Parpura-Gill","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.jagp.2016.04.013_bib0165","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0006-8993(02)03731-9","article-title":"Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1\u201340)","volume":"958","author":"Miguel-Hidalgo","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.jagp.2016.04.013_bib0170","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev.ne.17.030194.003033","article-title":"GABAA receptor channels","volume":"17","author":"Macdonald","year":"1994","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.jagp.2016.04.013_bib0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0197-4580(94)00150-2","article-title":"Anticonvulsants attenuate amyloid beta-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology","volume":"16","author":"Mark","year":"1995","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jagp.2016.04.013_bib0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-2007-1017143","article-title":"Benzodiazepine suppression of cortisol secretion: a measure of anxiolytic activity?","volume":"19","author":"Gram","year":"1986","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jagp.2016.04.013_bib0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1740925X12000129","article-title":"TSPO-specific ligand vinpocetine exerts a neuroprotective effect by suppressing microglial inflammation","volume":"7","author":"Zhao","year":"2011","journal-title":"Neuron Glia Biol"},{"key":"10.1016\/j.jagp.2016.04.013_bib0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain","volume":"342","author":"Xie","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jagp.2016.04.013_bib0195","first-page":"236re4","article-title":"An antidepressant decreases CSF Abeta production in healthy individuals and in transgenic AD mice","volume":"6","author":"Sheline","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jagp.2016.04.013_bib0200","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jagp.2016.04.013_bib0205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0891988715606230","article-title":"Cortical amyloid beta deposition and current depressive symptoms in Alzheimer disease and mild cognitive impairment","volume":"29","author":"Chung","year":"2016","journal-title":"J Geriatr Psychiatry Neurol"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748116301038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748116301038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T02:30:56Z","timestamp":1689993056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748116301038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1064748116301038"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2016.04.013","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzodiazepine Use Attenuates Cortical \u03b2-Amyloid and is Not Associated with Progressive Cognitive Decline in Nondemented Elderly Adults: A Pilot Study Using F18-Florbetapir Positron Emission Tomography","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2016.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}